Lineage Cell Therapeutics, Inc. LCTX
Set alert
1.00 USD -0.03 -2.91%
At close · Oct 30
1.02 +0.02 +1.69%
After hours · Oct 30, 4:00 PM ET
0.9821 Day range 1.05
0.88 52-week range 2.09
- YTD
- -40.12%
- 1 year
- -45.65%
- Open
- 1.04
- Prev close
- 1.03
- Mkt cap
- 252.91M
- Vol
- 1.17M
- Avg vol
- 1.25M
- EPS
- -0.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.9821
- High
- 1.05
- Forward P/E
- -3.66
- Beta
- 1.28
- Short ratio
- 35.21
- Inst. own
- 50.56%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.7364
- 200-d avg
- 0.96025
- 1y target
- 4.83
News
3 days ago businesswire.com
Lineage Provides Update on ReSonance® Program for Hearing Loss
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel,…
2 weeks ago benzinga.com
Transcript: Lineage Cell Therapeutics Q2 2026 Earnings Conference Call
On Thursday, Lineage Cell Therapeutics (AMEX:LCTX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by…